A dedicated clinical school on the use of concepts and skills of evidence-based care to solve controversial real-life problems in the management of cirrhosis. The course will focus on those areas of cirrhosis management where agreement is far from being…
This EASL school is dedicated to chronic alcohol related liver disease, covering all aspects of the patient’s journey through the healthcare system. From alcohol’s impact on citizens in the society, to early disease detection, biomarkers used in healthcare pathways from…
Autoimmune Hepatitis (AIH) and Primary Biliary Cholangitis (PBC) including their variants, encompass a wide spectrum of liver diseases with diverse pathophysiology, clinical presentation (or characteristics), management and prognosis. Aims of this course are to (1) recognize red flags for the…
The 2023 EASL-AASLD Masterclass is a unique opportunity for early-stage investigators in academic hepatology to take their careers to the next level. This two-day intensive training session will bring together clinical, basic, and translational scientists from leading academic medical institutions…
The objective of the School is to foster the clinical formation of young hepatologists in the area of advanced liver disease, and in particular in the field of portal hypertension, where important advancements are in progress. The School is scheduled…
Many of the limitations of cellular and animal models of liver disease can be overcome by using human precision cut liver slices and liver organoid cultures. These cutting-edge 3D models can recapitulate the complex multi-cellular pathways involved in liver injury and disease progression. In this Basic Science EASL school, each…
Liver cirrhosis is a major healthcare problem worldwide with a high mortality which is predominantly caused by complications of portal hypertension, e.g. variceal bleeding and ascites. Reduction of the portal pressure by implantation of a transjugular intrahepatic portosystemic shunt (TIPS) is the key in…
A dedicated clinical school in rare immune mediated liver diseases including PBC, AIH, PSC, IgG4 related disease, liver disease in patients with primary immunodeficiency and those treated with immune checkpoint inhibitors. The course will follow an inverted classroom model and…
